TARGETED THERAPY AND INFECTIONS IN RHEUMATIC DISEASES
In the past decade, rheumatology has shown clear progress in the practical introduction of biological agents (BAs) and targeted sintetic anti-inflammatory agents. At the same time, the use of these agents is associated with an increasing risk for infections of different origin and sites, including o...
Saved in:
Main Authors: | B. S. Belov, M. S. Naumtseva, G. M. Tarasova, D. V. Bukhanova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2016-12-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/712 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Herpes zoster virus infection and rheumatic diseases: Current state of the problem
by: D. V. Bukhanova, et al.
Published: (2016-09-01) -
Comorbid Infections in Rheumatic Diseases
by: B. S. Belov, et al.
Published: (2020-05-01) -
Vaccination in rheumatology: the present and prospects
by: Boris Sergeyevich Belov, et al.
Published: (2012-09-01) -
Lower respiratory tract infections in rheumatic diseases
by: B. S. Belov, et al.
Published: (2018-04-01) -
Role of biomarkers in the diagnosis of bacterial infections in rheumatic diseases
by: B. S. Belov, et al.
Published: (2019-07-01)